RxDoctor Payments Data

Catherine Yuen, PA

Physician Assistant · West Covina, CANPI 1275107369

Payments from drug & device makers

$1,115in general payments, 2019–2025

Across 48 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$278
  • Bayer$181
  • GSK$175
  • AbbVie$106
  • Novo Nordisk$101
  • Boehringer Ingelheim$78
  • plus $196 from 8 others

What the payments were for

  • Food & beverage$1,115100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,115 in reported general payments places this provider in the 70th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$1,298
Medicare patients
14
Services billed
16

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProliaDenosumab35$57,454
JanuviaSitagliptin Phosphate39$38,378
VascepaIcosapent Ethyl42$26,654
FarxigaDapagliflozin Propanediol25$24,606
JardianceEmpagliflozin27$24,427
OzempicSemaglutide15$16,569
TradjentaLinagliptin17$16,132
LinzessLinaclotide13$6,810
DapagliflozinDapagliflozin Propanediol12$5,876
Colesevelam Hcl20$1,609
Losartan Potassium106$1,144
Pravastatin Sodium79$1,059
Atorvastatin Calcium145$1,050
Olmesartan Medoxomil68$1,004
Raloxifene Hcl20$593

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$78$40,55944 claims
AstraZenecaFarxiga$53$24,60625 claims
Novo NordiskOzempic$101$16,56915 claims
AbbVieLinzess$106$6,81013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,423 physician assistant providers in California.

Other physician assistant in West Covina

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →